Target- |
Mechanism- |
Active Org.- |
|
Active Indication- |
|
Drug Highest PhasePending |
First Approval Ctry. / Loc.- |
First Approval Date- |
诺丽通颗粒治疗频繁阵发性紧张型头痛(Frequent paroxysmal tension type headache)(气血两虚证)随机、双盲、安慰剂对照、多中心Ⅲ期临床试验方案
[Translation] A randomized, double-blind, placebo-controlled, multicenter phase III clinical trial of Nolitong granules in the treatment of frequent paroxysmal tension type headache (Qi and blood deficiency syndrome)
1、进一步评价诺丽通颗粒治疗频繁阵发性紧张型头痛(气血两虚证)的疗效。 2、进一步观察诺丽通颗粒的安全性。
[Translation] 1. To further evaluate the efficacy of Nolitong Granules in treating frequent paroxysmal tension-type headaches (Qi and blood deficiency syndrome). 2. To further observe the safety of Nolitong Granules.
诺丽通颗粒治疗频发反复性紧张型头痛(气血两虚证)随机、双盲、安慰剂对照、多中心Ⅱ期临床试验
[Translation] A randomized, double-blind, placebo-controlled, multicenter phase II clinical trial of Nolitong granules in the treatment of frequent recurrent tension-type headache (Qi and blood deficiency syndrome)
1、初步评价诺丽通颗粒治疗频发反复性紧张型头痛(气血两虚证)的疗效。2、初步观察诺丽通颗粒的安全性。3、剂量探索,为Ⅲ期临床研究提供重要依据。
[Translation] 1. Preliminary evaluation of the efficacy of Nolitong Granules in treating frequent recurrent tension-type headaches (Qi and blood deficiency syndrome). 2. Preliminary observation of the safety of Nolitong Granules. 3. Dose exploration, providing important basis for Phase III clinical research.
100 Clinical Results associated with Beijing Plantai Pharmaceutical Technology Development Co., Ltd.
0 Patents (Medical) associated with Beijing Plantai Pharmaceutical Technology Development Co., Ltd.
100 Deals associated with Beijing Plantai Pharmaceutical Technology Development Co., Ltd.
100 Translational Medicine associated with Beijing Plantai Pharmaceutical Technology Development Co., Ltd.